Abstract:In this issue of the Journal, Verhoeven and colleagues (1) further document the association between depressive and anxiety disorders and shorter leukocyte telomere length (LTL), an indicator of cellular aging. The researchers, reporting data from 2,936 participants in the Netherlands Study of Depression and Anxiety (NESDA) (2), observed that participants with remitted and with current depressive and anxiety disorders show shorter LTL than never-affected controls across baseline and 6-year follow-up. The researchers controlled for lifestyle and somatic health variables known also to affect telomere length. As illustrated in Figure 2 of their report, the longitudinal course of illness over 6 years (e.g., new onset, persistent remission, relapse, chronic) was not associatedwith differences in LTL attrition rates. The investigators conclude that short LTL could be either a long-term consequence (“imprint”) of depression and anxiety or a biomarker of an underlying vulnerability factor for these commonmental disorders. The studywas not designed to address this conundrum conclusively. What is new about this study is its focus on the longitudinal course of illness and LTL attrition. In a previous crosssectional report published in Molecular Psychiatry and addressing depression and accelerated cellular aging (3), the investigators observed significantly shorter LTL in both currently depressed (5,461 base pairs) and remitted (5,459 base pairs) patients compared with controls (5,541 base pairs). These differences in length were estimated to be the equivalent of 4–6 years of accelerated physiologic—not chronologic—aging. As in the current study, the large sample size of NESDA participants permitted control for potential confounders such as smoking, body mass index, alcohol use, and physical activity. In the Molecular Psychiatry report, the investigators reported evidence of a dose-response gradient: both depression severity and duration of depressive symptoms in the previous 4 years were associated with shorter telomeres. That relationship appears not to have been confirmed in the current longitudinal study, which offered a much finer-grained analysis of illness course. The researchers haveposited that prior depression leaves a telomere scar even after the episode is over—that is, an “imprint” of past exposure to depression. They raise further questions of profound public health and clinical moment, for example, does telomere shortening contribute to medical comorbidities commonly seen in depressed patients, such as heart disease, diabetes, obesity, and cancer? Finally, they point out that how telomere length relates to treatment response is still unclear, although in the current report LTL was not found to be associated with cumulative antidepressant exposure. In order to place these observations in further context, this commentary will first summarize contemporary understanding of what telomeres are, their function, and their relationship to cellular aging. Secondly, the commentary will offer several observations emerging in the literature of geroscience that account for mechanisms of telomere shortening and the relevance of these mechanisms to common mental disorders like depression. Finally, to recapture a clinical perspective, recent observations relating depression treatment to reductions inmortality secondary to cancerwill be summarized.

Psychological Wellbeing and Healthy Aging: Focus on Telomeres

Exploring the interplay of psychological and biological components of stress response and telomere length in the transition from middle age to late adulthood: A systematic review

Telomere Biology in Mood Disorders: An Updated, Comprehensive Review of the Literature

The impact of oxidative DNA damage and stress on telomere homeostasis

Telomere Length - A Cellular Aging Marker for Depression and Post-Traumatic Stress Disorder

Stress and Aging Perspectives. Psychological and Neuro-Psychological Interventions

An integrative review of factors associated with telomere length and implications for biobehavioral research

Telomere Attrition: A Window Into Common Mental Disorders and Cellular Aging.

Association of Telomere Length, a Cellular Aging Marker, with Depression, PTSD and Hostility

Telomere dysfunction in ageing and age-related diseases

Ageing and the telomere connection: An intimate relationship with inflammation

Lifestyle effects on telomeric shortening as a factor associated with biological aging: A systematic review

Unravelling the role of telomere shortening with ageing and their potential association with diabetes, cancer, and related lifestyle factors

Telomere length, stem cells and aging

Telomere Biology and Human Phenotype

Psychological Stress and Cellular Aging in Cancer: A Meta-Analysis

Physical activity, a modulator of aging through effects on telomere biology

Telomere length in psychiatric disorders: Is it more than an ageing marker?

Telomere attrition and inflammation: the chicken and the egg story

Stress-induced biological aging: A review and guide for research priorities

Telomere length maintenance in aging and carcinogenesis.